EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel in vivo TDP-43 stress reporter models to accelerate drug development in ALS

Febe Ferro iD, C Roland Wolf iD, Christopher Henstridge iD, Francisco Inesta-Vaquera iD

Open Biology · 2024-10 · 14 (10)

DOI: 10.1098/rsob.240073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Biology, online erschienen am 30.10.2024. Verfasst von Febe Ferro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Systems and Cellular Medicine, University of Dundee, Dundee DD1 9SY, UK. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, DNA-Binding Proteins, Disease Models, Animal, Mice, Transgenic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MND Scotland, ARUK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of therapies to combat neurodegenerative diseases is widely recognized as a research priority. Despite recent advances in understanding their molecular basis, there is a lack of suitable early biomarkers to test selected compounds and accelerate their translation to clinical trials. We have investigated the utility of in vivo reporters of cytoprotective pathways (e.g. NRF2, p53) as surrogate early biomarkers of the ALS degenerative disease progression. We hypothesized that cellular stress observed in a model of ALS may precede overt cellular damage and could activate our cytoprotective pathway reporters. To test this hypothesis, we generated novel ALS-reporter mice by crossing the hTDP-43tg model into our oxidative stress/inflammation (Hmox1; NRF2 pathway) and DNA damage (p21; p53 pathway) stress reporter models. Histological analysis of reporter expression in a homozygous hTDP-43tg background demonstrated a time-dependent and tissue-specific activation of the reporters in tissues directly associated with ALS, before moderate clinical signs are observed. Further work is warranted to determine the specific mechanisms by which TDP-43 accumulation leads to reporter activation and whether therapeutic intervention modulates reporters’ expression. We anticipate the reporter strategy could be of great value in developing treatments for a range of degenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisDNA-Binding ProteinsDisease Models, AnimalMice, TransgenicGenes, ReporterAnimalsMiceHumansOxidative StressNF-E2-Related Factor 2Drug DevelopmentDNA DamageBiomarkers

Stichwörter der Autor:innen

TDP-43in vivopreclinical modelsreporters

Substanzen

DNA-Binding ProteinsNF-E2-Related Factor 2TARDBP protein, humanBiomarkersTardbp protein, mouse

Autor:innen und Institutionen

  • Systems and Cellular Medicine, University of Dundee, Dundee DD1 9SY, UK.
  • Department of Biochemistry and Molecular Biology and Genetics, University of Extremadura, Badajoz 06006, Spain.

ORCID-Profile: Febe Ferro, C Roland Wolf, Christopher Henstridge, Francisco Inesta-Vaquera

Förderung

  • MND Scotland
  • ARUK

Zitieren

APA

Ferro, F., Wolf, C. R., Henstridge, C., & Inesta-Vaquera, F. (2024). Novel in vivo TDP-43 stress reporter models to accelerate drug development in ALS. Open Biology, 14(10). https://doi.org/10.1098/rsob.240073

Vancouver

Ferro F, Wolf CR, Henstridge C, Inesta-Vaquera F. Novel in vivo TDP-43 stress reporter models to accelerate drug development in ALS. Open Biology. 2024;14(10). doi:10.1098/rsob.240073

BibTeX
@article{Ferro2024,
  author = {Ferro, Febe and Wolf, C Roland and Henstridge, Christopher and Inesta-Vaquera, Francisco},
  title = {Novel in vivo TDP-43 stress reporter models to accelerate drug development in ALS},
  journal = {Open Biology},
  year = {2024},
  volume = {14},
  number = {10},
  doi = {10.1098/rsob.240073}
}
Kostenlos starten →